Free Trial
NASDAQ:STAA

STAAR Surgical (STAA) Stock Price, News & Analysis

STAAR Surgical logo
$23.87 -0.68 (-2.77%)
Closing price 04:00 PM Eastern
Extended Trading
$24.10 +0.22 (+0.94%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About STAAR Surgical Stock (NASDAQ:STAA)

Advanced

Key Stats

Today's Range
$23.26
▼
$24.30
50-Day Range
$19.08
▼
$27.17
52-Week Range
$15.59
▼
$35.87
Volume
1.81 million shs
Average Volume
711,039 shs
Market Capitalization
$1.20 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$29.00
Consensus Rating
Hold

Company Overview

STAAR Surgical is a medical device company focused on ophthalmic surgery and vision correction. The company develops, manufactures and markets implantable lenses and related products designed to reduce or eliminate dependence on glasses or contact lenses.

Its principal product line is the EVO Visian Implantable Collamer Lens (ICL), a lens implanted inside the eye to correct myopia, with or without astigmatism. Unlike procedures that remove corneal tissue, ICL surgery preserves the eye’s natural lens and is designed to be removable. STAAR Surgical also offers other ophthalmic lenses and surgical products for refractive and cataract-related procedures, depending on the market.

Founded in 1982, STAAR Surgical serves ophthalmic surgeons and patients internationally through direct operations and distribution partners. Its products are marketed across the United States and numerous international markets, including countries in Europe and the Asia-Pacific region. The company is headquartered in Lake Forest, California, and its common stock trades on the Nasdaq under the symbol STAA.

AI Generated. May Contain Errors.

STAAR Surgical Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
69th Percentile Overall Score

STAA MarketRank™: 
3.474643950485 of 5 stars

STAAR Surgical scored higher than 69% of companies evaluated by MarketBeat, and ranked 280th out of 881 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    STAAR Surgical has received a consensus rating of Hold. The company's average rating score is 2.23, and is based on 1 strong buy rating, 4 buy ratings, 5 hold ratings, and 3 sell ratings.

  • Upside Potential

    STAAR Surgical has a consensus price target of $29.00, representing about 21.5% upside from its current price of $23.87.

  • Amount of Analyst Coverage

    STAAR Surgical has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about STAAR Surgical's stock forecast and price target.
  • Earnings Growth

    Earnings for STAAR Surgical are expected to grow by 48.72% in the coming year, from $0.39 to $0.58 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of STAAR Surgical is -2,387,000.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of STAAR Surgical is -2,387,000.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    STAAR Surgical has a P/B Ratio of 3.19. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    12.10% of the float of STAAR Surgical has been sold short.
  • Short Interest Ratio / Days to Cover

    STAAR Surgical has a short interest ratio ("days to cover") of 6.76.
  • Change versus previous month

    Short interest in STAAR Surgical has recently decreased by 1.25%, indicating that investor sentiment is improving.
  • Dividend Yield

    STAAR Surgical does not currently pay a dividend.

  • Dividend Growth

    STAAR Surgical does not have a long track record of dividend growth.

  • News Sentiment

    STAAR Surgical has a news sentiment score of 0.43. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 16 news articles for STAAR Surgical this week, compared to 5 articles on an average week.
  • Search Interest

    Only 1 people have searched for STAA on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.
  • MarketBeat Follows

    Only 1 people have added STAAR Surgical to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, STAAR Surgical insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    39.90% of the stock of STAAR Surgical is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    96.70% of the stock of STAAR Surgical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about STAAR Surgical's insider trading history.
Receive STAA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for STAAR Surgical and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

STAA Stock News Headlines

STAAR Surgical (NASDAQ:STAA) Stock Rating Upgraded by Wall Street Zen
Top Trader Reveals Stunning Black Friday Deal
Others paid $500 for the Snapback Indicator. This Black Friday, it's available for just $7. Base Camp Trading's Thomas Wood calls it one of the firm's most powerful proprietary trading indicators, and says the company has never run a deal like this before. There are no strings attached, just a steep Black Friday discount on a tool built for traders.tc pixel
STAAR Surgical (STAA) Q3 2026 Earnings Call Transcript
STAAR Surgical Reports Third Quarter 2026 Results
See More Headlines

STAA Stock Analysis - Frequently Asked Questions

STAAR Surgical's stock was trading at $23.09 at the beginning of 2026. Since then, STAA stock has increased by 3.4% and is now trading at $23.87.

STAAR Surgical Company (NASDAQ:STAA) issued its earnings results on Wednesday, November, 4th. The medical instruments supplier reported $0.11 EPS for the quarter, beating the consensus estimate of $0.05 by $0.06. The business's revenue for the quarter was down 11.9% on a year-over-year basis.
Read the conference call transcript
.

STAAR Surgical's board authorized a stock buyback program on Thursday, September 24th 2026, which permits the company to repurchase $50 million in outstanding shares, according to EventVestor. This means that the company could purchase up to 5.2% of its shares through open market purchases. Shares buyback programs are typically a sign that the company's board of directors believes its shares are undervalued.

STAAR Surgical subsidiaries include Canon Staar, Frigitronics Inc., STAAR Japan Inc., STAAR Optical Equipment, STAAR Surgical AG, STAAR Surgical PTE. LTD, and Technology (Shanghai) Co. LTD.

STAAR Surgical's top institutional shareholders include Two Seas Capital LP (2.60%), Defender Capital LLC. (0.86%), Roubaix Capital LLC (0.30%) and Public Sector Pension Investment Board (0.20%). Insiders that own company stock include Broadwood Partners, LP, Aimee S Weisner and Arthur C Butcher.
View institutional ownership trends
.

Shares of STAA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that STAAR Surgical investors own include NVIDIA (NVDA), Tesla (TSLA), CrowdStrike (CRWD), Roku (ROKU), Trade Desk (TTD), PayPal (PYPL) and Teladoc Health (TDOC).

Company Calendar

Last Earnings
11/04/2026
Today
11/10/2026
Stifel 2026 Healthcare Conference 2026
11/10/2026
Canaccord Genuity's MedTech, Diagnostics and Digital Health & Services Forum
11/11/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Equipment & Supplies
Sub-Industry
Healthcare Equipment
Current Symbol
NASDAQ:STAA
CIK
718937
Employees
957
Year Founded
1982

Price Target and Rating

High Price Target
$37.00
Low Price Target
$13.00
Potential Upside/Downside
+21.5%
Consensus Rating
Hold
Rating Score (0-4)
2.23
Research Coverage
13 Analysts

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
41.16
P/E Growth
N/A
Net Income
-$80.45 million
Net Margins
0.16%
Pretax Margin
1.70%
Return on Equity
8.43%
Return on Assets
6.50%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
4.68
Quick Ratio
4.08

Sales & Book Value

Annual Sales
$239.44 million
Price / Sales
5.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$7.49 per share
Price / Book
3.19

Miscellaneous

Outstanding Shares
50,200,000
Free Float
30,171,000
Market Cap
$1.20 billion
Optionable
Optionable
Beta
1.22

Social Links

7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

This page (NASDAQ:STAA) was last updated on 11/10/2026 by MarketBeat.com Staff.
From Our Partners